Peer-influenced content. Sources you trust. No registration required. This is HCN.



A Combination of Cancer Inhibitors Shows Success in Slowing Tumor Growth

Oncology, Medical September 19th 2023

The New England Journal of Medicine

Atezolizumab for Advanced Alveolar Soft Part Sarcoma

Oncology, Medical September 11th 2023

Medical Professionals Reference (MPR)

Akeega, an Oral Combo Therapy for BRCA-Mutated mCRPC, Gets FDA Approval

Oncology, Medical August 21st 2023

Cancer Therapy Advisor

Therapy Selection in Small Cell Lung Cancer with Disease Progression After Platinum-Based Therapy

Oncology, Medical August 21st 2023

Oncology Learning Network

Ibrutinib Combined with Obinutuzumab and Venetoclax for the Frontline Treatment of Older Patients with CLL

Hematology/Oncology August 14th 2023


Changes to the SCLC Treatment Landscape Stirs Up Hope for Oncologists

Oncology, Medical August 1st 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form